BeiGene Announces Board and Officer Changes
Ticker: BEIGF · Form: 8-K · Filed: Sep 26, 2024 · CIK: 1651308
| Field | Detail |
|---|---|
| Company | Beigene, LTD. (BEIGF) |
| Form Type | 8-K |
| Filed Date | Sep 26, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.0001, $400,000, $65,000, $17,500 |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, officer-changes, director-changes
Related Tickers: BGNE
TL;DR
BeiGene shuffled its board and execs, expect updates on compensation soon.
AI Summary
On September 25, 2024, BeiGene, Ltd. filed an 8-K report detailing changes in its board of directors and executive officers. The filing includes information regarding the election of new directors and the appointment of certain officers, as well as updates on compensatory arrangements for these individuals. Specific details on the individuals involved and the terms of their compensation are provided within the document.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: low — This filing primarily concerns routine corporate governance changes and does not appear to involve significant financial risks or operational disruptions.
Key Players & Entities
- BeiGene, Ltd. (company) — Registrant
- September 25, 2024 (date) — Date of Report
- Cayman Islands (location) — Jurisdiction of Incorporation
- Mourant Governance Services (Cayman) Limited (company) — Address of Principal Executive Offices
FAQ
Who were the directors or officers whose departure or appointment was reported?
The filing indicates changes in directors and officers but does not list specific names in the provided excerpt. The full document would contain these details.
What is the effective date of these reported changes?
The date of the earliest event reported is September 25, 2024.
What specific items are being reported under the 8-K filing?
The filing covers the Departure of Directors or Certain Officers, Election of Directors, Appointment of Certain Officers, and Compensatory Arrangements of Certain Officers, as well as Financial Statements and Exhibits.
Where is BeiGene, Ltd. incorporated?
BeiGene, Ltd. is incorporated in the Cayman Islands.
What is the principal executive office address for BeiGene, Ltd.?
The principal executive offices are located at c/o Mourant Governance Services (Cayman) Limited, 94 Solaris Avenue, Camana Bay, Grand Cayman KY1-1108, Cayman Islands.
Filing Stats: 1,261 words · 5 min read · ~4 pages · Grade level 10.4 · Accepted 2024-09-26 06:12:21
Key Financial Figures
- $0.0001 — resenting 13 Ordinary Shares, par value $0.0001 per share BGNE The NASDAQ Global Sele
- $400,000 — ant Ms. Sharp equity awards valued at US$400,000, pro-rated in the first year of service
- $65,000 — o receive annual cash compensation of US$65,000 for her service as a director on the Bo
- $17,500 — Board and annual cash compensation of US$17,500 for her service as a member of the Audi
Filing Documents
- bgne-20240925.htm (8-K) — 40KB
- a20240926formxnewdirectora.htm (EX-99.1) — 12KB
- image_0.jpg (GRAPHIC) — 53KB
- 0001651308-24-000118.txt ( ) — 251KB
- bgne-20240925.xsd (EX-101.SCH) — 2KB
- bgne-20240925_lab.xml (EX-101.LAB) — 21KB
- bgne-20240925_pre.xml (EX-101.PRE) — 12KB
- bgne-20240925_htm.xml (XML) — 3KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits . Exhibit No. Description 99.1 Press release titled "Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors" issued by BeiGene, Ltd. on September 26, 2024 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL Exhibit Index Exhibit No. Description 99.1 Press release titled "Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors" issued by BeiGene, Ltd. on September 26, 2024 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BEIGENE, LTD. Date: September 26, 2024 By: /s/ Chan Lee Name: Chan Lee Title: Senior Vice President, General Counsel